dc.contributor.author
Shanina, Elena
dc.contributor.author
Siebs, Eike
dc.contributor.author
Zhang, Hengxi
dc.contributor.author
Silva, Daniel Varon
dc.contributor.author
Joachim, Ines
dc.contributor.author
Titz, Alexander
dc.contributor.author
Rademacher, Christoph
dc.date.accessioned
2021-08-09T13:13:28Z
dc.date.available
2021-08-09T13:13:28Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/31572
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-31304
dc.description.abstract
The carbohydrate-binding protein LecA (PA-IL) from Pseudomonas aeruginosa plays an important role in the formation of biofilms in chronic infections. Development of inhibitors to disrupt LecA-mediated biofilms is desired but it is limited to carbohydrate-based ligands. Moreover, discovery of drug-like ligands for LecA is challenging because of its weak affinities. Therefore, we established a protein-observed 19F (PrOF) nuclear magnetic resonance (NMR) to probe ligand binding to LecA. LecA was labeled with 5-fluoroindole to incorporate 5-fluorotryptophanes and the resonances were assigned by site-directed mutagenesis. This incorporation did not disrupt LecA preference for natural ligands, Ca2+ and d-galactose. Following NMR perturbation of W42, which is located in the carbohydrate-binding region of LecA, allowed to monitor binding of low-affinity ligands such as N-acetyl d-galactosamine (d-GalNAc, Kd = 780 ± 97 μM). Moreover, PrOF NMR titration with glycomimetic of LecA p-nitrophenyl β-d-galactoside (pNPGal, Kd = 54 ± 6 μM) demonstrated a 6-fold improved binding of d-Gal proving this approach to be valuable for ligand design in future drug discovery campaigns that aim to generate inhibitors of LecA.
en
dc.format.extent
7 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
drug discovery
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie::570 Biowissenschaften; Biologie
dc.title
Protein-observed 19F NMR of LecA from Pseudomonas aeruginosa
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1093/glycob/cwaa057
dcterms.bibliographicCitation.journaltitle
Glycobiology
dcterms.bibliographicCitation.number
2
dcterms.bibliographicCitation.pagestart
159
dcterms.bibliographicCitation.pageend
165
dcterms.bibliographicCitation.volume
31
dcterms.bibliographicCitation.url
https://doi.org/10.1093/glycob/cwaa057
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Chemie und Biochemie
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1460-2423
refubium.resourceType.provider
WoS-Alert